| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |